Tara Ortiz, MD
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,757 of the $2,511 with a category attached, or 70.0%. 11 manufacturers reported payments, led by Medtronic at 47.0% of the total. Reporting peaked in 2023 at $1,420 and has fallen 97.5% since, to $36 in 2025. That places this record below the midpoint for urology clinicians in TX, where the typical reported total is $3,394.
Across 44 payments — averaging $57.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Boston Scientific$848
- Axonics, Inc.$150
- 180 Medical, Inc.$110
- Coloplast$79
- Rochester Medical Corporation$40
- plus $103 from 5 others
What the payments were for
- Travel & lodging$75430%
- Food & beverage$1,75770%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 13 | $1,181 |
| Boston Scientific | 13 | $848 |
| Axonics, Inc. | 1 | $150 |
| 180 Medical, Inc. | 5 | $110 |
| Coloplast | 4 | $79 |
| Rochester Medical Corporation | 2 | $40 |
| Antares Pharma, Inc. | 2 | $35 |
| Dentsply IH Inc. | 1 | $22 |
| Myriad Genetic Laboratories, Inc. | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $13 |
| Laborie Medical Technologies Corp. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$907
- Bulkamid$150
- Axonics$150
- GENERAL MALE SUI$139
- AMS 800 Artificial Urinary Sphincter$138
- AMS 700$121
How this compares
$2,511 in reported general payments places this provider in the 40th percentile of 878 urology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 84 | $46,281 |
| JatenzoTestosterone Undecanoate | 15 | $18,427 |
| GemtesaVibegron | 24 | $18,371 |
| Mirabegron ErMirabegron | 14 | $6,979 |
| Trospium Chloride ErTrospium Chloride | 13 | $3,753 |
| Testosterone | 30 | $3,599 |
| Estradiol | 45 | $3,431 |
| Solifenacin Succinate | 82 | $2,465 |
| Tamsulosin Hcl | 138 | $1,764 |
| Testosterone Cypionate | 42 | $1,594 |
| NitrofurantoinNitrofurantoin Macrocrystal | 30 | $1,431 |
| Methenamine Hippurate | 17 | $1,324 |
| Potassium Citrate ErPotassium Citrate | 19 | $1,229 |
| Finasteride | 60 | $794 |
| Trimethoprim | 16 | $793 |
Paid to pharmacies, not to this prescriber.
Other urology in Buda
- Andrew von EschenbachMontgomery$3.2M
- Brian MazzarellaLakeway$1.2M
- Arun RaiHouston$920K
- Allen MoreyDallas$914K
- Donald GriffithHouston$732K
- Michael TrotterAustin$590K
- Vitaly MargulisDallas$555K
- Daniel SaltzsteinSan Antonio$547K
- Leroy JonesSan Antonio$506K
- Jonathan Clavell HernandezHouston$500K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.